Pharma channel feed

Ahead of like­ly ap­proval, ICER finds Geron’s ime­tel­stat is not cost-ef­fec­tive at $250,000 an­nu­al­ly

Last year
FDA+

Blue­bird bio starts 15 pa­tients on its three mul­ti­mil­lion-dol­lar gene ther­a­pies

Last year
Cell/Gene Tx

Up­dat­ed: Take­da to re­vamp in mul­ti­year quest, piv­ots CAR-NK ther­a­py from can­cer to au­toim­mune

Last year

House pan­el marks up bill to re­quire PBMs to use a flat fee in Medicare

Last year
FDA+

In­side CVS Care­mark’s move that broke Hu­mi­ra’s hold on the mar­ket

Last year
Health Tech

Te­va to close ad­di­tion­al man­u­fac­tur­ing sites as it en­ters next phase of 'piv­ot to growth'

Last year
Manufacturing

As­traZeneca pulls Covid-19 vac­cine glob­al­ly as the phar­ma sees 'no fu­ture com­mer­cial de­mand'

Last year
R&D
Coronavirus

Pa­tient dies in Pfiz­er’s Phase 2 Duchenne mus­cu­lar dy­s­tro­phy tri­al

Last year

White House un­veils long-await­ed pol­i­cy on over­see­ing re­search of con­cern

Last year
FDA+

Madri­gal 'en­cour­aged' by ear­ly launch progress of land­mark NASH drug

Last year

Ver­tex touts Cas­gevy sick­le cell launch as blue­bird makes progress with ri­val Lyf­ge­nia

Last year
Cell/Gene Tx

Sen. Cas­sidy calls on Biden to do bet­ter at shar­ing H5N1 bird flu in­for­ma­tion

Last year
FDA+

In­dus­try groups cri­tique new guid­ance for Medicare drug price ne­go­ti­a­tions in 2027

Last year
FDA+

As­traZeneca ex­pands stake in cell and gene ther­a­py part­ner Cel­lec­tis

Last year
Financing
Cell/Gene Tx

Pfiz­er hires Citi an­a­lyst Baum to over­see port­fo­lio strat­e­gy

Last year
People

J&J show­cas­es more blad­der can­cer re­sults from 'pret­zel' drug-de­vice com­bo

Last year
R&D

Sen­a­tors from both par­ties in­tro­duce menopause re­search bill

Last year

Ab­b­Vie puts $161M in­to new R&D site in Ger­many, will add 300 jobs

Last year
R&D

House to mark up bill tar­get­ing Chi­nese biotech and ge­nomics com­pa­nies

Last year
China

Dig­i­tal health start­up Ro’s CEO talks GLP-1 drug pric­ing, short­ages and com­pound­ed shots

Last year
Health Tech

Bi­par­ti­san draft bill would pay hos­pi­tals more to com­bat drug short­ages

Last year
Manufacturing

Phar­ma com­pa­nies soft­en tone on full IRA im­pact

Last year

Block­buster can­cer drug Calquence hits pri­ma­ry end­point in tri­al for first-line man­tle cell lym­phoma

Last year
R&D

ICER push­es back on FDA's po­ten­tial con­ver­sion of Sarep­ta's gene ther­a­py to full ap­proval

Last year
Cell/Gene Tx
FDA+
First page Previous page 54555657585960 Next page Last page
A service from the Financial Times